Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.
about
Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer.Platelet-to-lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta-analysisPretreatment neutrophil-to-lymphocyte ratio as a survival predictor for small-cell lung cancer.Transient Ischemic Attack Versus Seizure: Use of Complete Blood Count Parameters for Differential Diagnosis.Cervical cancer systemic inflammation score: a novel predictor of prognosisClinical Usefulness of the Platelet-to Lymphocyte Ratio in Patients with Angiosarcoma of the Face and Scalp.The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.Impact of celecoxib on inflammation during cancer surgery: a randomized clinical trial.Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma.Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio can predict the severity of gallstone pancreatitis.Comparing Postoperative Complications and Inflammatory Markers Using Total Intravenous Anesthesia Versus Volatile Gas Anesthesia for Pancreatic Cancer Surgery.Combined Use of the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as a Prognostic Predictor in Patients with Operable Soft Tissue Sarcoma.Validation of Different Nutritional Assessment Tools in Predicting Prognosis of Patients with Soft Tissue Spindle-Cell Sarcomas.Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resectionPrognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma: A meta-analysisBiological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio in soft tissue sarcoma
P2860
Q36023938-9B7B8855-8364-4E41-9287-C8C98172BFFAQ37063842-FD0CBD1E-F699-4919-914C-B39246A3D7DCQ39322836-85795C42-E920-474E-B5E1-99A003A76669Q39363595-9737A2F8-0217-4690-B762-C0901D8BB1D2Q39991182-9A97380F-B851-481A-BC5F-A004B2A832F2Q47153024-6753D939-B46C-42AF-914A-C5F968CE7CB5Q47338550-1FFA835D-9296-4AC9-83DE-C83AD0B0A0C5Q47341907-EDA6273F-9675-4891-B38B-3ADB7ABFDCF6Q47685069-9FB05CB7-1647-42A5-AE27-867426DE3F80Q48164452-E79B90BA-2397-4C1E-A057-05560E62695CQ49984474-F6DC074D-35CB-40FD-89BF-72B0DD0AA2A7Q55236680-4AB4239C-16F3-4757-A6CE-B78FF3A795AFQ55515113-E0A0E79F-D6A2-4D5F-B205-9CB7864B7FCDQ58698876-7091C741-53E9-46DA-A2F5-6D68DE4257DCQ58759331-73FDDDAF-922F-47FA-A775-4C65873BF547Q58790889-C71006C8-6671-4437-A902-790A6898A478
P2860
Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Preoperative platelet-lymphocy ...... actor for soft-tissue sarcoma.
@ast
Preoperative platelet-lymphocy ...... actor for soft-tissue sarcoma.
@en
type
label
Preoperative platelet-lymphocy ...... actor for soft-tissue sarcoma.
@ast
Preoperative platelet-lymphocy ...... actor for soft-tissue sarcoma.
@en
prefLabel
Preoperative platelet-lymphocy ...... actor for soft-tissue sarcoma.
@ast
Preoperative platelet-lymphocy ...... actor for soft-tissue sarcoma.
@en
P2093
P2860
P1433
P1476
Preoperative platelet-lymphocy ...... actor for soft-tissue sarcoma.
@en
P2093
Xing Zhang
Yongming Chen
Yuanfang Li
Zhiwei Zhou
P2860
P2888
P356
10.1186/S12885-015-1654-6
P407
P577
2015-10-02T00:00:00Z
P5875
P6179
1010995739